Guidelines for high dose chemotherapy and stem cell transplantation for systemic AL amyloidosis: EHA-ISA working group guidelines
2021 · Amyloid · 103 citations
https://doi.org/10.1080/13506129.2021.2002841
P
Peter Mollee
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
386
Papers
6.2K
Citations
34
h-index
118
i10-index
Peter Mollee is an academic researcher from The University of Queensland. The author has contributed to research in topics: Multiple Myeloma Research and Treatments & Amyloidosis: Diagnosis, Treatment, Outcomes & Chronic Lymphocytic Leukemia Research. The author has an h-index of 34, co-authored 329 publications.
ORCID: 0000-0002-8537-1198Papers by this author
worksA Randomized Phase III Trial of Melphalan and Dexamethasone (MDex) Versus Bortezomib, Melphalan and Dexamethasone (BMDex) for Untreated Patients with AL Amyloidosis
2016 · Blood · 62 citations
https://doi.org/10.1182/blood.v128.22.646.646
Design and development of the Australian and New Zealand (ANZ) myeloma and related diseases registry
2016 · BMC Medical Research Methodology · 34 citations
https://doi.org/10.1186/s12874-016-0250-z
Cardiac “hypertrophy” phenotyping: differentiating aetiologies with increased left ventricular wall thickness on echocardiography
2023 · Frontiers in Cardiovascular Medicine · 15 citations
https://doi.org/10.3389/fcvm.2023.1183485
An Individualized Exercise Intervention for People with Multiple Myeloma—Study Protocol of a Randomized Waitlist-Controlled Trial
2022 · Current Oncology · 7 citations
https://doi.org/10.3390/curroncol29020077
Safety, Feasibility, and Acceptability of a Multisite Individualized Exercise Intervention for People with Multiple Myeloma
2023 · Medicine & Science in Sports & Exercise · 4 citations
https://doi.org/10.1249/mss.0000000000003267
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat